FCF Yield

Amgen’s current free cash flow (FCF) yield of 4.6% means that for every $100 you invest in the stock, the company generates $4.60 in annual free cash flow — the cash left after operating expenses and capital spending.

This yield sits just above the healthcare sector median of 4.5%, placing Amgen in the 59th percentile among its peers, so slightly more attractive than the typical stock in its sector. The metric has been perfectly stable over the last eight quarters, with year-over-year and quarter-over-quarter changes both at exactly +0.0%. When a company’s FCF yield is modestly above the sector median and shows no movement, it suggests a consistent cash-generation profile with neither a clear upside opportunity nor a looming risk from deterioration. This combination of a slightly positive level and flat trend aligns with and supports the overall NEUTRAL verdict, as the stock offers a steady, unremarkable cash return without a catalyst for re-rating.

Frequently Asked Questions

Closest Sector Peers